Showing 151 - 159 of 159
A growing chorus of voices is sounding a common refrain - the U.S. Patent and Trademark Office (PTO) is issuing far too many bad patents. These criticisms are complicated by the rather surprising fact that we don't actually know what percentage of patent applications actually issue as patents....
Persistent link: https://www.econbiz.de/10014049128
The Bayh-Dole Act of 1980 facilitated the retention by universities of patent rights resulting from government funded academic research, thus encouraging university entry into patenting and licensing. Though the Act is widely recognized to be a major change in federal policy towards academic...
Persistent link: https://www.econbiz.de/10014054030
Observers worry that generic patent challenges are on the rise and reduce the effective market life of drugs. A related concern is that challenges disproportionately target high-sales drugs, reducing market life for these “blockbusters.” To study these questions, we examine new data on...
Persistent link: https://www.econbiz.de/10014182616
Persistent link: https://www.econbiz.de/10014183616
Patent law both imposes a duty on patent applicants to submit relevant prior art to the PTO and assumes that examiners use this information to determine an application's patentability. In this paper, we test the validity of these assumptions by studying the use made of applicant-submitted prior...
Persistent link: https://www.econbiz.de/10014192614
Growth during the 1980s and 1990s in patenting and licensing by American universities is frequently asserted to be a direct consequence of the Bayh-Dole Act of 1980. However, there has been little empirical analysis of the effects of this legislation. This paper uses previously unexploited data...
Persistent link: https://www.econbiz.de/10014053892
The U.S. government has funded university research for nearly 80 years, with a significant share of this funding supporting the fixed costs of science through indirect cost recovery (ICR). We explain the history, objectives, and mechanics of ICR policy and review key controversies. We also...
Persistent link: https://www.econbiz.de/10015361503
During World War II, the U.S. Committee on Medical Research (CMR) undertook an integrated, cross-sectoral effort to develop medical science and technology for war, representing the U.S. government's first substantial investment in medical research. Using data on all CMR research contracts, we...
Persistent link: https://www.econbiz.de/10015326451
Persistent link: https://www.econbiz.de/10015404473